We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Quantitative Molecular Diagnostic Methods Identify Causes of Childhood Diarrhea

By LabMedica International staff writers
Posted on 06 Oct 2016
Print article
Image: A formulated custom TaqMan array card (Photo courtesy of Thermo Fisher Scientific).
Image: A formulated custom TaqMan array card (Photo courtesy of Thermo Fisher Scientific).
The number of cases of childhood diarrhea attributed to pathogens such as bacteria, parasites, viruses or other infections has been substantially underestimated and may be nearly twice as high as previous analysis suggests.

Worldwide, diarrhea remains the second leading cause of death in children under five years old, and is associated with approximately half a million deaths per year. Management of diarrhea usually involves supportive care with rehydration and zinc supplementation. Antibiotics are not usually recommended unless there are signs of dysentery, severe diarrhea with the presence of blood and mucus in the stools or if cholera is suspected.

A large team of scientists collaborating with those at the University of Virginia (Charlottesville, VA, USA) re-analyzed stool samples from 10.608 children with and without diarrhea obtained from regions in seven countries in Asia (Bangladesh, India and Pakistan) and Africa (The Gambia, Kenya, Mali, and Mozambique), which were from the Global Enteric Multicenter Study (GEMS). Previous estimates of the infectious causes of diarrhea were based on a variety of different detection methods, but this study, for the first time, uses a molecular diagnostic testing method called quantitative real-time polymerase chain reaction (qPCR) to test for 32 pathogens.

The scientists formulated a custom TaqMan Array Card (Thermo Fisher, Carlsbad, CA, USA) that compartmentalized probe-based qPCR assays for 32 enteropathogens. This platform has shown high reproducibility within and across sites. All the assays have been described previously and have been extensively validated. Nucleic acid was extracted with the QIAamp Fast DNA Stool mini kit (Qiagen, Hilden, Germany) with pretreatment steps that included bead beating.

The original GEMS study1, published in 2013, estimated that 51.5% of childhood diarrhea cases could be attributed to pathogens, but the new re-analysis finds the proportion is much higher at 89.3%. The original study identified four major pathogens: rotavirus, Shigella spp, Cryptosporidium spp, and heat-stable enterotoxin-producing Escherichia coli (ST-ETEC). This re-analysis reaffirmed these four and added two others: adenovirus 40/41 and Campylobacter jejuni/coli. Together, these six pathogens accounted for 77.8% of all diarrheas. Among the children who had a diarrhea-causing pathogen, about half had more than one infection highlighting the challenges of treating multiple infections.

Eric R Houpt, MD, a professor of Infectious Diseases and a senior author of the study said, “Childhood diarrhea remains an enormous problem, made more confusing by the long list of possible infections, the difficulties in diagnosis, and the large number of undiagnosed cases. We developed sensitive quantitative methods that levelled the diagnostic playing field and closed the diagnostic gap.” The study was published on September 24, 2016, in the journal The Lancet.

Related Links:
University of Virginia
Thermo Fisher Scientific
Qiagen
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.